DrugPatentWatch Database Preview
Taro Company Profile
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
There are ten US patents protecting TARO drugs. There are three tentative approvals on TARO drugs.
There are sixty-two patent family members on TARO drugs in seventeen countries and eighty-five supplementary protection certificates in twelve countries.
Summary for Taro
| International Patents: | 62 |
| US Patents: | 10 |
| Tradenames: | 111 |
| Ingredients: | 94 |
| NDAs: | 211 |
| Patent Litigation for Taro: | See patent lawsuits for Taro |
| PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | TOPICORT | desoximetasone | OINTMENT;TOPICAL | 018763-001 | Sep 30, 1983 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Taro | TOPICORT | desoximetasone | GEL;TOPICAL | 018586-001 | Mar 29, 1982 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Taro Pharm | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 076362-002 | Dec 2, 2003 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Taro | FLUOCINONIDE | fluocinonide | CREAM;TOPICAL | 071500-001 | Jun 10, 1987 | AB1 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ➤ Try a Free Trial |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 5,881,926 | ➤ Try a Free Trial |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,102,254 | ➤ Try a Free Trial |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 5,881,926 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
Premature patent expirations for TARO
Expiration due to failure to pay maintenance fee
| Patent Number | Expiration Date |
|---|---|
| ➤ Try a Free Trial | ➤ Try a Free Trial |
Non-Orange Book US Patents for Taro
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,957,238 | Process for preparing malathion for pharmaceutical use | ➤ Try a Free Trial |
| 5,886,038 | Composition and method for treatment of psoriasis | ➤ Try a Free Trial |
| 8,536,155 | Process for preparing malathion for pharmaceutical use | ➤ Try a Free Trial |
| 8,039,657 | Process for preparing malathion for pharmaceutical use | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Taro Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2616112 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 9962498 | ➤ Try a Free Trial |
| Spain | 2276697 | ➤ Try a Free Trial |
| Japan | 2013032405 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB97/064 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
| C/GB07/011 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003 |
| 90062-5 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
| C/GB05/030 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
